Know more

Our use of cookies

Cookies are a set of data stored on a user’s device when the user browses a web site. The data is in a file containing an ID number, the name of the server which deposited it and, in some cases, an expiry date. We use cookies to record information about your visit, language of preference, and other parameters on the site in order to optimise your next visit and make the site even more useful to you.

To improve your experience, we use cookies to store certain browsing information and provide secure navigation, and to collect statistics with a view to improve the site’s features. For a complete list of the cookies we use, download “Ghostery”, a free plug-in for browsers which can detect, and, in some cases, block cookies.

Ghostery is available here for free: https://www.ghostery.com/fr/products/

You can also visit the CNIL web site for instructions on how to configure your browser to manage cookie storage on your device.

In the case of third-party advertising cookies, you can also visit the following site: http://www.youronlinechoices.com/fr/controler-ses-cookies/, offered by digital advertising professionals within the European Digital Advertising Alliance (EDAA). From the site, you can deny or accept the cookies used by advertising professionals who are members.

It is also possible to block certain third-party cookies directly via publishers:

Cookie type

Means of blocking

Analytical and performance cookies

Realytics
Google Analytics
Spoteffects
Optimizely

Targeted advertising cookies

DoubleClick
Mediarithmics

The following types of cookies may be used on our websites:

Mandatory cookies

Functional cookies

Social media and advertising cookies

These cookies are needed to ensure the proper functioning of the site and cannot be disabled. They help ensure a secure connection and the basic availability of our website.

These cookies allow us to analyse site use in order to measure and optimise performance. They allow us to store your sign-in information and display the different components of our website in a more coherent way.

These cookies are used by advertising agencies such as Google and by social media sites such as LinkedIn and Facebook. Among other things, they allow pages to be shared on social media, the posting of comments, and the publication (on our site or elsewhere) of ads that reflect your centres of interest.

Our EZPublish content management system (CMS) uses CAS and PHP session cookies and the New Relic cookie for monitoring purposes (IP, response times).

These cookies are deleted at the end of the browsing session (when you log off or close your browser window)

Our EZPublish content management system (CMS) uses the XiTi cookie to measure traffic. Our service provider is AT Internet. This company stores data (IPs, date and time of access, length of the visit and pages viewed) for six months.

Our EZPublish content management system (CMS) does not use this type of cookie.

For more information about the cookies we use, contact INRA’s Data Protection Officer by email at cil-dpo@inra.fr or by post at:

INRA
24, chemin de Borde Rouge –Auzeville – CS52627
31326 Castanet Tolosan CEDEX - France

Dernière mise à jour : Mai 2018

Menu Logo Principal logo envt small Logo INP-EI Purpan Logo UPS-Tlse3

Home page

Zone de texte éditable et éditée et rééditée

E23 TRiX: Transcriptomic impact of Xenobiotics

LogoTRiX
© TRiX
Technological Platform on Transcriptomics (GeT - TRiX)

Transcriptomics as a relevant tool to answer current questions in toxicology

Transcriptomic represents a powerful tool to evaluate the impact of various stimuli on biological systems. By measuring the abundance of thousands of transcripts simultaneously, one can reveal both specific gene expression changes and modulations of entire pathways. Recent developments in transcriptomic data analysis further enable 1) to reveal subtle impacts affecting groups of coregulated genes, even when their individual statistical significance can be doubtful and 2) to integrate transcriptomic data with other levels of observations such as proteomic or metabolomic data. These new possibilities emphasize the advantages transcriptomic offers to study the effects of xenobiotics mixture and low doses and to couple the impacts on the transcriptome to their potential causes or consequences at the phenotypic level.

Development of the TRiX transcriptomic facility at TOXALIM

Since 2000, the Integrative Toxicology & Metabolism group has developed a substantial experience in transcriptomic studies (from foused macroarrays to genome-wide screenings) and high-throughput data analysis (from data pre-processing/filtering to high-level data integration). Based on this experience and on funding by INRA and the Region Midi-Pyrénées (CPER 2007-2013), we propose to develop the TRiX facility (TRanscriptomic impact of Xenobiotics) in order to provide an easy access to expertise and tools to perform transcriptomic studies with Agilent microarrays. TRiX would be fully integrated with the GenoToul biochips platform (biopuce.insa-toulouse.fr) which established an Affymetrix platform and provides several equipments and services for a variety of applications on biochips. TRiX will be open to any project from local, national or international actors of the academic or industrial sectors.

To complete the panel of technologies available to the community, we propose to set up an Agilent platform (including an Agilent scanner) and to develop services which include statistical analysis of the data. Agilent technology is highly complementary to Affymetrix platform, in particular due to its greater flexibility (whole genomes or easy custom chip designs, one- or two-color designs). Based on our experience, the use of an Agilent scanner with Agilent microarrays significantly improves precision and reproducibility.

In addition to Agilent microarray screenings, TRiX will provide an environment suitable for high-throughput or targeted gene expression studies and aims at developing future services for targeted promoter analysis. TiRX will be initially set-up by Pascal Martin (IR2, Integrative Toxicology & Metabolism group), who is specialized in transcriptomics and involved in coordinating the GenoToul biostatistic platform (www.math.univ-toulouse.fr/biostat).

Projects workflow at the TRiX facility

Our short-term project is to provide the workflows presented below for whole-genome or targeted gene expression studies (services provided by TRiX are in blue and products delivered to TRiX client are in red):

In the medium term, TRiX aims at providing effective services for all steps of the gene expression workflows including hands-on manipulations, QC and statistical data analysis reports as well as to develop a reliable quality assurance system (ISO 9001). TRiX will aim at obtaining labels from INRA-CNOC (Commission Nationale des Outils Collectifs) and from the GIS-IBiSA (Infrastructures en Biologie Santé et Agronomie) together with the GenoToul Biochips platform. Additional services for the targeted analysis of promoters would also be developed.

Current TOXALIM Projects using transcriptomics with microarrays: projects PNRPE and Région Midi-Pyrénées on Fipronil and flame retardants (C Viguié), ANR PlastImpact (T Pineau), ANR Metaprofile (JL Sebedio), ANR ExpoMatPest (L Payrastre), ANR HemeCancer (F Pierre), EU 7th FP MycoRed (I Oswald), Priority action of the Nutrition, Chemical Food Safety and Consumer Behaviour division of INRA on Bisphenol-A (E Houdeau), INRA-Formas project on lipid metabolism (H Guillou).